ESC Premium Access

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.

Presentation

About the speaker

Professor Michael D Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
3 presentations
0 follower

Access the full session

Meet the Trialists - EMANATE

Speakers: Professor M. Ezekowitz
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk